Ramy Rahmé

4PUBLICATIONS
21CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 28, 2025
Mutant p53 regulates a distinct gene set by a mode of genome occupancy that is shared with wild type.

Ramy Rahmé, Lois Resnick-Silverman, Vincent Anguiano

|May 16, 2023
TP53 Alterations in Myelodysplastic Syndromes and Acute Myeloid Leukemia.

Ramy Rahmé, Thorsten Braun, James J Manfredi

|Apr 06, 2021
OncoAlert Round Table Discussions: The Global COVID-19 Experience.

Gilberto Morgan, Evandro de Azambuja, Kevin Punie

|Feb 18, 2021
Eprenetapopt Plus Azacitidine in TP53-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM).

Thomas Cluzeau, Marie Sebert, Ramy Rahmé

Pageof 1